TY - JOUR
T1 - Cell type- and region-specific enhancement of adult hippocampal neurogenesis by daidzein in middle-aged female mice
AU - Yamada, Jun
AU - Hatabe, Jun
AU - Tankyo, Kaori
AU - Jinno, Shozo
PY - 2016/12/1
Y1 - 2016/12/1
N2 - Adult hippocampal neurogenesis is associated with various brain functions, such as learning, memory, and emotion. Intriguingly, reduction in new cell production in the hippocampus in middle age may underlie some of the cognitive deficits. Among several factors that may affect adult hippocampal neurogenesis, estrogens have been suggested to be critically involved in the cognitive impairment of postmenopausal women. Phytoestrogens, such as daidzein and genistein, are expected to work as estrogen substitutes. In this study, we aimed to clarify the effects of daidzein on adult hippocampal neurogenesis using middle-aged (12-month-old) female mice. Animals received daily intraperitoneal injections of daidzein or vehicle for four weeks, and the cells at specific stages of neurogenesis were presumptively defined using molecular markers. Administration of daidzein did not affect the numerical densities (NDs) of primary progenitors, early transient amplifying progenitors (TAPs), and astrocytes. In contrast, the NDs of late TAPs, neural progenitors, and immature granule cells were increased by daidzein. The NDs of proliferating cells, but not apoptotic cells, were also increased by daidzein. To examine the effects of daidzein on maturation of adult-born cells, we three-dimensionally traced their dendritic arbors: the branch number, total length, and intersection number (Sholl analysis) of immature granule cells were increased by daidzein. In general, the effects of daidzein were more dominant in the dorsal region than in the ventral region. The cell type- and region-specific enhancement of adult hippocampal neurogenesis by daidzein provides a key to understanding the actions of estrogen substitutes for the treatment of postmenopausal women.
AB - Adult hippocampal neurogenesis is associated with various brain functions, such as learning, memory, and emotion. Intriguingly, reduction in new cell production in the hippocampus in middle age may underlie some of the cognitive deficits. Among several factors that may affect adult hippocampal neurogenesis, estrogens have been suggested to be critically involved in the cognitive impairment of postmenopausal women. Phytoestrogens, such as daidzein and genistein, are expected to work as estrogen substitutes. In this study, we aimed to clarify the effects of daidzein on adult hippocampal neurogenesis using middle-aged (12-month-old) female mice. Animals received daily intraperitoneal injections of daidzein or vehicle for four weeks, and the cells at specific stages of neurogenesis were presumptively defined using molecular markers. Administration of daidzein did not affect the numerical densities (NDs) of primary progenitors, early transient amplifying progenitors (TAPs), and astrocytes. In contrast, the NDs of late TAPs, neural progenitors, and immature granule cells were increased by daidzein. The NDs of proliferating cells, but not apoptotic cells, were also increased by daidzein. To examine the effects of daidzein on maturation of adult-born cells, we three-dimensionally traced their dendritic arbors: the branch number, total length, and intersection number (Sholl analysis) of immature granule cells were increased by daidzein. In general, the effects of daidzein were more dominant in the dorsal region than in the ventral region. The cell type- and region-specific enhancement of adult hippocampal neurogenesis by daidzein provides a key to understanding the actions of estrogen substitutes for the treatment of postmenopausal women.
UR - http://www.scopus.com/inward/record.url?scp=84985897209&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84985897209&partnerID=8YFLogxK
U2 - 10.1016/j.neuropharm.2016.08.036
DO - 10.1016/j.neuropharm.2016.08.036
M3 - Article
C2 - 27580847
AN - SCOPUS:84985897209
VL - 111
SP - 92
EP - 106
JO - Neuropharmacology
JF - Neuropharmacology
SN - 0028-3908
ER -